FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction BPC 157 FDA approval status 2026: Is it legal? Veedma